Identifikasi Drug Related Problems (DRPs) pada Pasien Diabetes Melitus di RS Multazam Kota Gorontalo

Abstract

Diabetes Mellitus (DM) is a disease marked by high blood glucose level due t the body cannot release or use sufficient insulin. The management of DM medication therapy requires a long period of time, it can affect life quality of patient and can cause Drug Related Problems (DRPs). The DRPs is frequently occurred and causing less optimum medication. The research aimed to find out the type and percentage of DRPs based on anti-diabetes medication at diabetes mellitus patients with or without disease. This was descriptive research which was done retrospectively. The technique of determining sample/ data applied purposive sampling and obtained 24 samples that were appropriate with research inclusion criteria. The research finding showed that group of anti-diabetic medication ecompassed biguanide (metformin), sulfonylurea (glimepiride, gliclazide, gliquidone, and glibenclamide), inhibitor -glucosidase (acarbose, miglitol), thiazolidinedione (rosiglitazone, troglitazone, pioglitazone), meglitinide (repaglinide), and phenylalanine derivate (nateglinide), as well as insulin while based on identification of DRPs potential with following order category was namely right drug (drug without indication for 20%, indication without drug for 20%, combination of wrong drug for 6.67%, wrong drug selection for 6.67%), right dose category (too high dose for 13.33% and too low dose for 0%), and drug interaction category for 33.33%.